Liothyronine sodium hydrate (Synonyms: 三碘代甲状腺素钠盐水合物; Triiodothyronine sodium hydrate; 3,3′,5-Triiodo-L-thyronine sodium hydrate; T3 sodium hydrate)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Liothyronine sodium hydrate  (Synonyms: 三碘代甲状腺素钠盐水合物; Triiodothyronine sodium hydrate; 3,3′,5-Triiodo-L-thyronine sodium hydrate; T3 sodium hydrate)

Liothyronine sodium hydrate 是一种有效的甲状腺激素。Liothyronine sodium hydrate 是有效的 TRα 和 TRβ 激动剂，对 hTRα 和 hTRβ 的 Ki 值均为 2.33 nM。

Liothyronine sodium hydrate (Synonyms: 三碘代甲状腺素钠盐水合物; Triiodothyronine sodium hydrate; 3,3

Liothyronine sodium hydrate Chemical Structure

CAS No. : 345957-19-9

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Liothyronine sodium hydrate 的其他形式现货产品:

Liothyronine sodium Liothyronine

Liothyronine sodium hydrate 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

Liothyronine sodium hydrate is an active form of thyroid hormone. Liothyronine sodium hydrate is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2][3].

IC50 & Target

Human Endogenous Metabolite

 

体外研究
(In Vitro)

Liothyronine (T3, 100 nM) sodium hydrate stimulates the proliferation of hepatocarcinema cells in which TRβ1 is overexpressed[1]. Liothyronine sodium hydrate binds to human β1 thyroid hormone receptor (hTRβ1), and changes its conformation. Liothyronine sodium hydrate promotes growth, induces differentiation and regualtes metabolic effects[2].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Liothyronine sodium hydrate 相关抗体:
Clinical Trial

Formula

C15H12I3NO4.xH2O.Na
CAS 号

345957-19-9
中文名称

三碘代甲状腺素钠盐水合物
结构分类
  • Phenols
  • Monophenols
初始来源
  • 内源性代谢物
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (529 KB) 产品使用指南 (1538 KB)

参考文献

  • [1]. Lin KH, et al. Stimulation of proliferation by 3,3′,5-triiodo-L-thyronine in poorly differentiated human hepatocarcinoma cells overexpressing beta 1 thyroid hormone receptor. Cancer Lett. 1994 Oct 14;85(2):189-94.  [Content Brief]

    [2]. Bhat MK, et al. Conformational changes of human beta 1 thyroid hormone receptor induced by binding of 3,3′,5-triiodo-L-thyronine. Biochem Biophys Res Commun. 1993 Aug 31;195(1):385-92.  [Content Brief]

    [3]. Hiroaki Shiohara, et al. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia. Bioorg Med Chem. 2012 Jun 1;20(11):3622-34.  [Content Brief]

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务